SCHEMBL14224753

SCHEMBL14224753

Cn1cc(NC(=O)c2cc(NC(=O)c3ccc(Cl)cc3F)cn2CCCO)cc1-c1nc2cccnc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.42
MLLT1 Q03111 2/20 0.36
CTNNB1 P35222 2/20 0.35
TCF7L2 Q9NQB0 2/20 0.35
HTR1F P30939 1/20 0.34
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
FSCN1 Q16658 1/20 0.33
GRM4 Q14833 2/20 0.33
GPR27 Q9NS67 1/20 0.33
MAPK1 P28482 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SLC6A9 P48067 1/20 0.32
CSNK1D P48730 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224798 0.92 CYP11B2 (0.40) CYP11B2MLLT1CTNNB1TCF7L2HTR1F
SCHEMBL14224675 0.90 MAPT (0.43) CYP11B2MLLT1CTNNB1TCF7L2NPC1
SCHEMBL14224553 0.85 AURKA (0.35) CYP11B2FSCN1
SCHEMBL14427755 0.84 FPR1 (0.35) NPC1HTTRAB9AMAPK1MAPT
SCHEMBL14224801 0.82 CYP11B2 (0.39) CYP11B2MLLT1CTNNB1TCF7L2NPC1
SCHEMBL14224793 0.82 CYP11B2 (0.36) CYP11B2MLLT1CTNNB1TCF7L2HTR1F
SCHEMBL14224802 0.82 MAPT (0.41) CYP11B2MLLT1CTNNB1TCF7L2NPC1
SCHEMBL14224795 0.77 FPR1 (0.34) HTTMAPK1MAPT
SCHEMBL14224526 0.77 CBLB (0.36) HTT
SCHEMBL14099810 0.76 CYP11B2 (0.45) CYP11B2MLLT1CTNNB1TCF7L2HTR1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 CYP11B2 1414/4885MLLT1 837/4885CTNNB1 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.